story of the week
Overall Survival With Pembrolizumab in Patients With Early-Stage TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
N. Engl. J. Med 2024 Sep 15;[EPub Ahead of Print], P Schmid, J Cortes, R Dent, H McArthur, L Pusztai, S Kümmel, C Denkert, YH Park, R Hui, N Harbeck, M Takahashi, SA Im, M Untch, PA Fasching, MA Mouret-Reynier, T Foukakis, M Ferreira, F Cardoso, X Zhou, V Karantza, K Tryfonidis, G Aktan, J O'ShaughnessyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.